News and Press Releases

Inocras Closes $31 Million in Oversubscribed Series B-3 Financing to Accelerate U.S. Commercial Expansion

AimedBio To Integrate Inocras’ Whole-Genome Analysis Tools Into Clinical Programs

Inocras Announces ASCO 2026 Online Publication: Whole-genome HRD phenotyping as a predictor of PARP inhibitor benefit in first-line maintenance high-grade serous ovarian cancer

Revisiting The Cancer Genome Atlas From a Whole-Genome View

Inocras and Broad Institute Researchers Present New TCGA Whole-Genome Cancer Insights, Accelerating Discovery in Cancer Genomics

Inocras and Broad Institute Researchers Will Release Novel Insights From TCGA Cancer Whole-Genome Analysis at AACR Annual Meeting 2026, Empowering a New Era of Precision Oncology

How AI Is Changing NGS Workflows

Accent Therapeutics to Utilize Inocras’ CancerVision™ and MRDVision™ Platforms in Phase 1/2 ATX-295 Clinical Study

Powering Precision Oncology with Whole-Genome Insights

A Look Ahead: Predictions for the Life Sciences in 2026